Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1).
J Immunother Cancer. 2023 Mar;11(3):e005301. doi: 10.1136/jitc-2022-005301.
J Immunother Cancer. 2023.
PMID: 36927527
Free PMC article.
Clinical Trial.
Cite
Cite